MX2022015792A - Composiciones farmaceuticas topicas. - Google Patents

Composiciones farmaceuticas topicas.

Info

Publication number
MX2022015792A
MX2022015792A MX2022015792A MX2022015792A MX2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A MX 2022015792 A MX2022015792 A MX 2022015792A
Authority
MX
Mexico
Prior art keywords
topical pharmaceutical
pharmaceutical compositions
patient
relates
oil phase
Prior art date
Application number
MX2022015792A
Other languages
English (en)
Inventor
Piyush Jain
Robert Michael Leming
Glenn Tabolt
Alan Scott Colborn
Original Assignee
Dermavant Sciences GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermavant Sciences GmbH filed Critical Dermavant Sciences GmbH
Publication of MX2022015792A publication Critical patent/MX2022015792A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a composiciones de emulsión farmacéuticas tópicas que comprenden una cantidad terapéuticamente eficaz de 3,5-dihidroxi-4-isopropil-trans-estilbe no o una sal farmacéuticamente aceptable del mismo, una fase oleosa, una fase acuosa, un agente tensioactivo y un antioxidante, y en donde la composición de emulsión es homogénea y/o el principio activo se solubiliza en la fase oleosa. La invención también se refiere a métodos para tratar una condición o trastorno dermatológico en un paciente mediante la administración de las presentes composiciones a la piel del paciente.
MX2022015792A 2020-06-24 2021-06-24 Composiciones farmaceuticas topicas. MX2022015792A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063043360P 2020-06-24 2020-06-24
US202063043340P 2020-06-24 2020-06-24
PCT/US2021/038794 WO2021262917A1 (en) 2020-06-24 2021-06-24 Topical pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2022015792A true MX2022015792A (es) 2023-02-27

Family

ID=79281807

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015792A MX2022015792A (es) 2020-06-24 2021-06-24 Composiciones farmaceuticas topicas.

Country Status (9)

Country Link
US (1) US20230225987A1 (es)
EP (1) EP4171529A4 (es)
JP (1) JP2023531489A (es)
KR (1) KR20230026497A (es)
AU (1) AU2021296867A1 (es)
CA (1) CA3183195A1 (es)
IL (1) IL298827A (es)
MX (1) MX2022015792A (es)
WO (1) WO2021262917A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925153B2 (en) * 2013-12-06 2018-03-27 Stc.Unm Therapeutic agents for skin diseases and conditions
US11617724B2 (en) * 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
US10195160B2 (en) * 2015-05-21 2019-02-05 Dermavant Sciences GmbH Topical pharmaceutical compositions
US11497718B2 (en) * 2018-11-13 2022-11-15 Dermavant Sciences GmbH Use of tapinarof for the treatment of atopic dermatitis
US20200147000A1 (en) * 2018-11-13 2020-05-14 Dermavant Sciences GmbH Use of tapinarof for the treatment of chronic plaque psoriasis

Also Published As

Publication number Publication date
WO2021262917A1 (en) 2021-12-30
KR20230026497A (ko) 2023-02-24
IL298827A (en) 2023-02-01
JP2023531489A (ja) 2023-07-24
CA3183195A1 (en) 2021-12-30
US20230225987A1 (en) 2023-07-20
EP4171529A1 (en) 2023-05-03
EP4171529A4 (en) 2024-05-01
AU2021296867A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
PH12017502092A1 (en) Topical pharmaceutical compositions
KR101420599B1 (ko) 항여드름제를 함유하는 조성물 및 이의 용도
MX2020010907A (es) Mejora de suministro de agentes activos lipofilicos a traves de la barrera hematoencefalica y metodos para tratar trastornos del sistema nervioso central.
JP2016515525A5 (es)
US20080076831A1 (en) Hemorrhoid reliever and method of use
TW201417822A (zh) 用於治療痤瘡的局部用組成物
WO2014190179A2 (en) Urea silicon gel for scars and hydration treatment and method of using same
RU2017140078A (ru) Косметический способ и его терапевтическое применение для уменьшения объема жировой ткани
JP2000247893A (ja) 抗菌剤、入浴剤組成物及び皮膚洗浄剤組成物
MX2022015792A (es) Composiciones farmaceuticas topicas.
JP2015081244A (ja) ニキビ治療用医薬組成物
RU2297224C2 (ru) Дерматологическая композиция, содержащая никотиновую кислоту или амид и сфингоидное основание
CN110944649B (zh) 鼠李糖及其衍生物作为抗真菌剂的用途
ES2332452T3 (es) Hidroxipiridinonas para el tratamiento local de trastornos microcirculatorios de la piel.
MX2018013477A (es) Acidos carboxilicos para tratar/prevenir una enfermedad de la piel.
JP7299682B2 (ja) 皮膚外用組成物
JP7299683B2 (ja) 皮膚外用組成物
JP2020100576A (ja) 皮膚外用組成物
JP7329910B2 (ja) 皮膚外用組成物
US20060019935A1 (en) Composition and method for treating acne including anti-inflammatory Hepes Oleate
JP2002338476A (ja) 腎透析に伴う痒みの予防治療剤
JPH08165244A (ja) 皮膚疾患治療剤
MX2023009424A (es) Composicion antitranspirante.
WO2021102072A1 (en) Composition and method for skin treatment
US20240082136A1 (en) Topical composition